Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study of the Analgesic Efficacy and Safety of Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Category & Conditions: Immune System Diseases and Conditions
Medicine: tanezumab
ClinicalTrials.gov Identifier (NCT): NCT02709486
Protocol ID: A4091057
PrintDownloadOpen Plain Language Summary Result: Click here